Showing results (231-240 of 273) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|July 26, 2023
Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or EnzalutamideForest Riekhof, Yan Yan, Charles L Bennett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular featuresG Badalamenti, V Rodolico, F Fulfaro, et al.
Critical Care Medicine|April 23, 2026
Effects of Early Versus Delayed Mechanical Thrombectomy on Outcomes in Intermediate-Risk Acute Pulmonary EmbolismCaleb J Chiang, Kelsey E Bria, Pavlina Chrysafi, et al.
British Journal of Clinical Pharmacology|May 7, 2022
Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERSLachlan L Dalli, Monique F Kilkenny, Isabelle Arnet, et al.
Heart, Lung & Circulation|September 25, 2010
Incidence of and case fatality following acute myocardial infarction in Aboriginal and non-Aboriginal Western Australians (2000-2004): a linked data studyJudith M Katzenellenbogen, Frank M Sanfilippo, Michael S T Hobbs, et al.
Journal of Clinical Epidemiology|November 27, 2010
Variable effects of prevalence correction of population denominators on differentials in myocardial infarction incidence: a record linkage study in Aboriginal and non-Aboriginal Western AustraliansJudith M Katzenellenbogen, Frank M Sanfilippo, Michael S T Hobbs, et al.
European Journal of Preventive Cardiology|July 30, 2011
Aboriginal to non-Aboriginal differentials in 2-year outcomes following non-fatal first-ever acute MI persist after adjustment for comorbidityJudith M Katzenellenbogen, Frank M Sanfilippo, Michael S T Hobbs, et al.
European Heart Journal. Digital Health|May 22, 2024
Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF studyJuan Lu, Arnaud Bisson, Mohammed Bennamoun, et al.
Prostate Cancer and Prostatic Diseases|September 14, 2022
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Journal of the National Cancer Institute|July 7, 2016
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States VeteransDaphne Y Xiao, Suhong Luo, Katiuscia O'Brian, et al.
Pageof 28